Administered Prices: Hearings, Eighty-fifth Congress, First Session Pursuant to S. Res. 56U.S. Government Printing Office, 1957 - 232 páginas |
Dentro del libro
Resultados 1-3 de 57
Página 15468
... therapeutically active substance , and one or more other therapeutically active in- gredients are hereby defined as " Licensed Products B " . " The letter identification of old Paragraphs C and D thereof shall be changed respectively to ...
... therapeutically active substance , and one or more other therapeutically active in- gredients are hereby defined as " Licensed Products B " . " The letter identification of old Paragraphs C and D thereof shall be changed respectively to ...
Página 15560
... therapeutically active substance and no other therapeutically active ingredient are hereby defined as " Licensed Products A " ; Licensed Products contain- ing such therapeutically active substance and one or more other therapeutically ...
... therapeutically active substance and no other therapeutically active ingredient are hereby defined as " Licensed Products A " ; Licensed Products contain- ing such therapeutically active substance and one or more other therapeutically ...
Página 15782
... therapeutically active ingredients which are not Licensed Ingredients , the Net Sales Price of such Licensed ... therapeutically active ingredient thereof during such quarter calendar year , or if there were no sales of Licensed Products ...
... therapeutically active ingredients which are not Licensed Ingredients , the Net Sales Price of such Licensed ... therapeutically active ingredient thereof during such quarter calendar year , or if there were no sales of Licensed Products ...
Contenido
Page | 15331 |
Foreign license agreements of Bristol Laboratories and related | 15458 |
ExhibitsContinued | 15726 |
Otras 22 secciones no mostradas
Otras ediciones - Ver todas
Términos y frases comunes
added to Schedule Allen & Hanburys amended America American Cyanamid Company and/or annexed hereto antibiotic substance aplastic anemia Application being filed Article FOURTH BRISTOL hereby BRISTOL LABORATORIES INC chloramphenicol Chloromycetin Chlortetracycline commensurate to pending confidential know-how corporation organized cycline DAVIS & COMPANY deemed to mean drug duly authorized effect fermentation filed commensurate Filing Date hereby agrees hereinafter defined hereinafter referred HOECHST Issue Date January July laws LEPETIT letter license agreement Licensed Cyanamid Patents Licensed Patents Licensed Products Finished LICENSEE LICENSEE'S Licensor manufacture organized and existing Paragraph Parke Davis Parke-Davis parties hereto Patent Applications Serial patent rights payable pending United penicillin Pfizer priority date priority date thereof products containing pursuant respect retailers rights and licenses royalties sales of Licensed Sales Price secret formulae secret processes sublicense subsidiaries or affiliates Supplemental Agreement termination Territory Tetracycline therapeutically active ingredients third party trade trademarks United States dollars United States Patent WHEREAS York